Author

Y. Barash

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Cancer Biology· 3 Immunology· 2 Cell Biology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Assay:bulk RNA-seq· 6 Organism:human· 6 Research Focus:differential expression· 4 Approach:statistical model· 4 Research Focus:cell type annotation· 3 Approach:experimental assay· 2 Approach:deep learning· 1 Research Focus:drug response / drug discovery· 1

Frequent Co-Authors

A. Thomas-Tikhonenko· 5 shared K. E. Hayer· 4 shared K. W. Lynch· 3 shared S. Y. Yang· 3 shared V. Pillai· 3 shared A. S. Naqvi· 2 shared C. D. Falkenstein· 2 shared K. L. Black· 2 shared

Activity by Year

2018-2023 · peak 2/yr

Co-Author Collaboration Network

10 top collaborators · 38 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

5 shared papersCancer Biology

A. Thomas-Tikhonenko

Mutual co-authors in cluster

Author profile →

6 papers

Recent·Most cited

An Alternatively Spliced Gain-of-Function NT5C2 Isoform Contributes to Chemoresistance in Acute Lymphoblastic Leukemia

M. T. Diz, C. Reglero, C. D. Falkenstein, A. Castro, K. E. Hayer, C. Radens, M. Quesnel-Vallieres, Z. Ang, P. Sehgal, M. M. Li, Y. Barash, S. K. Tasian, A. Ferrando, A. Thomas-Tikhonenko

The paper identifies an alternatively spliced NT5C2 isoform contributing to chemoresistance in B-ALL by enhancing nucleosidase activity and 6-MP resistance.

bioRxiv · Sep 14, 2023Cancer Biology

Alternative splicing of its 5'-UTR limits CD20 mRNA translation and enables resistance to CD20-directed immunotherapies

Z. Ang, L. Paruzzo, K. E. Hayer, C. Schmidt, M. Torres Diz, F. Xu, U. Zankharia, Y. Zhang, S. Soldan, S. Zheng, C. D. Falkenstein, J. P. Loftus, S. Y. Yang, M. Asnani, P. King Sainos, , A. Thomas-Tikhonenko

This study identifies alternative splicing of CD20 mRNA that generates translation-deficient isoforms, contributing to resistance to CD20-directed immunotherapies.

bioRxiv · Feb 19, 2023Immunology

FBXW7β isoform drives transcriptional activation of a proinflammatory TNF cluster in normal and malignant pro-B cells

S. Y. Yang, K. E. Hayer, H. Fazelinia, M. Asnani, K. L. Black, A. S. Naqvi, V. Pillai, L. A. Spruce, Y. Barash, K. S. Elenitoba-Johnson, A. Thomas-Tikhonenko

The paper identifies FBXW7β as a predominant isoform in normal and malignant pro-B cells, showing it drives a proinflammatory TNF gene cluster.

bioRxiv · Apr 24, 2022 · PreprintCell Biology

Identifying common transcriptome signatures of cancer by interpreting deep learning models

A. Jha, M. Quesnel-Vallieres, A. Thomas-Tikhonenko, K. W. Lynch, Y. Barash

This study identifies common transcriptome signatures across cancer types using deep learning models trained on RNA-Seq data, revealing genes and splicing variations associated with cancer.

bioRxiv · Nov 11, 2021Cancer Biology

Meta-Analysis of Transcriptomic Variation in T cell Populations Reveals Novel Signatures of Gene Expression and Splicing

C. M. Radens, D. Blake, P. Jewell, Y. Barash, K. W. Lynch

This study performs a meta-analysis of RNA-Seq data from human T cell subsets to identify consistent gene expression and splicing signatures across subtypes.

bioRxiv · Aug 9, 2019Immunology

Aberrant splicing in B-cell acute lymphoblastic leukemia

K. L. Black, A. S. Naqvi, K. E. Hayer, S. Y. Yang, E. Gillespie, A. Bagashev, V. Pillai, S. Tasian, M. R. Gazzara, M. Carroll, D. Taylor, K. W. Lynch, Y. Barash, A. Thomas-Tikhonenko

The paper identifies widespread aberrant splicing in pediatric B-ALL, showing that splicing factor deregulation drives splicing changes and contributes to disease.

Nucleic Acids Research · Oct 24, 2018Peer-reviewedCancer Biology